Invited review: Physiological properties of bioactive peptides obtained from whey proteins

Journal of Dairy Science

Volumn 93, Issue 2, 2010, Pages 437-455

  Madureira, A R ^a   Tavares, T ^a   Gomes, A M P ^a   Pintado, M E ^a   Malcata, F X ^a  

^a UNIVERSIDADE CATÓLICA PORTUGUESA   (Portugal)

Author keywords

Bioactivity; Bovine; Peptide; Whey

Indexed keywords

MILK PROTEIN; PEPTIDE; WHEY PROTEIN;

CHEMISTRY; HUMAN; METABOLISM; NUTRITION; PHYSIOLOGY; PROTEIN STABILITY; REVIEW;

HUMANS; MILK PROTEINS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; PEPTIDES; PROTEIN STABILITY;

BOVINAE;

EID: 77949290825     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2009-2566     Document Type: Review

References (143)

1. Abubakar A., Saito T., Kitazawa H., Kawai Y., Itoh T. Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion. J. Dairy Sci. 1998, 81:3131-3138.
2. Andersen J.H., Jenssen H., Gutterberg T.J. Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir. Antiviral Res. 2003, 58:209-215.
3. Andersen J.H., Osbakk S.A., Vorland L.H., Travik T., Gutterberg T.J. Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomelogavirus into human fibroblasts. Antiviral Res. 2001, 51:141-149.
4. Antila P., Paakkari I., Järvinen A., Mattila M.J., Laukkanen M., Pihlanto-Leppälä A., Mäntsälä P., Hellman J. Opioid peptides derived from in vitro proteolysis of bovine whey proteins. Int. Dairy J. 1991, 1:215-229.
5. Barbeau J., Gauthier S.F., Pouliot Y. Thermal stabilization of β-lactoblobulin by whey peptide factions. J. Agric. Food Chem. 1996, 44:3939-3945.
6. Baró L., Jiménez J., Martínez-Férez A., Bouza J. Bioactive milk peptides and proteins. Ars Pharmaceutica 2001, 42:135-145.
7. Bayless K.J., David G.E., Meininger G.A. Isolation and biological properties of osteopontin from bovine milk. Protein Expr. Purif. 1997, 9:309-314.
8. Bellamy W., Takase M., Wakabayashi H., Kawase K., Tomita M. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J. Appl. Bacteriol. 1992, 73:472-479.
9. Bellamy W., Takase M., Yamauchi K., Wakabayashi H., Kawase K., Tomita M. Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta 1992, 1121:130-136.
10. Bellamy W., Wakabayashi H., Takase M., Kawase K., Shimamura S., Tomita M. Role of cell binding in the antibacterial mechanism of lactoferricin B. J. Appl. Bacteriol. 1993, 75:478-484.
11. Bellamy W., Yamauchi K., Wakabayashi H., Takase M., Takakura N., Shimamura S. Antifungal properties of lactoferricin B, a peptide derived from the N-terminal region of bovine lactoferrin. Lett. Appl. Microbiol. 1994, 18:230-233.
12. Berthou J., Migliore-Samour D., Lifchitz A., Delettre J., Floch F., Jolles P. Immunostimulating properties and three-dimensional structure of two tripeptides from human and cow caseins. FEBS Lett. 1987, 218:55-58.
13. Beucher M., Levenez F., Yvon Y., Corring T. Effect of caseinomacropeptide (CMP) of cholecystokinin (CCK) release in rats. Reprod. Nutr. Dev. 1994, 34:613-614.
14. Biziulevicius G.A., Kislukhina O.V., Kazlauskaite J., Zukaite V. Food-protein enzymatic hydrolysates possess both antimicrobial and immunostimulatory activities: A " cause and effect" theory of bifunctionality. FEMS Immunol. Med. Microbiol. 2006, 46:131-138.
15. Bordenave S., Sannier F., Ricart G., Piot J.M. Continuous hydrolysis of goat whey in an ultrafiltration reactor: Generation of alpha-lactorphin. Prep. Biochem. Biotechnol. 1999, 29:189-202.
16. Boza J.J., Martínez-Augustin O., Gil A. Nutritional and antigenic characterization of an enzymatic whey protein hydrolysate. J. Agric. Food Chem. 1995, 43:872-875.
17. Brody E.P. Biological activities of bovine glycomacropeptide. Br. J. Nutr. 2000, 84:39-46.
18. Campagna S., Mathot A.-G., Fleury Y., Girardet J.-M., Gaillard J.-L. Antibacterial activity of lactophoricin, a synthetic 23-residue peptide derived from the sequence of bovine milk component-3 of proteose peptone. J. Dairy Sci. 2004, 87:1621-1626.
19. Cassens P.W.J.R., Visser S., Gruppen H., Voragen A.G.J. β-Lactoglobulin hydrolysis. 1. Peptide composition and functional properties of hydrolysates obtained by the action of plasmin, trypsin, and Staphylococcus aureus V8 protease. J. Agric. Food Chem. 1999, 47:2973-2979.
20. Chernikov M.P., Nikolskaya G.V., Stan E.Y., Shlygun G.K., Vasilevskaya L.S. Biological role of κ-casein glycomacropeptide. Vopr. Pitan. 1974, 2:21-25.
21. Cheung H.S., Wang F.L., Ondetti M.A., Sabo E.F., Cushman D.W. Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence. J. Biol. Chem. 1980, 225:401-407.
22. Chiba H., Yoshikawa M. Bioactive peptides derived from food proteins. Kagaku To Seibutsu 1991, 29:454-458.
23. Creusot N., Gruppen H. Enzyme-induced aggregation and gelation of proteins. Biotechnol. Adv. 2006, 25:597-601.
24. Denhardt D.T., Noda M. Osteopontin expression and function: Role in bone remodelling. J. Cell. Biochem. 1998, 30-31:92-102.
25. di Biase A.M., Pietrantoni A., Tinari A. Heparin-interacting sites of bovine lactoferrin are involved in anti-adenovirus activity. J. Med. Virol. 2003, 69:495-502.
26. Didelot S., Bordenave-Juchereau S., Rosenfeld E., Piot J.-M., Sannier F. Peptides released from acid goat whey by a yeast-lactobacillus association isolated from cheese microflora. J. Dairy Res. 2006, 6:163-170.
27. Dionysius D.A., Milne J.M. Antibacterial peptides of bovine lactoferrin 494: Purification and characterization. J. Dairy Sci. 1997, 80:667-674.
28. Dziuba J., Minkiewicz P. Influence of glycosylation on content of both micelle-stabilizing ability and biological properties of the C-terminal fragments of cow's κ-casein. Int. Dairy J. 1996, 6:1017-1044.
29. el-Salam A.M.H., el-Shibiny S., Buchheim W. Characteristics and potential uses of the casein macropeptide. Int. Dairy J. 1996, 6:327-341.
30. Facon M.J., Sakura B.J. Antibacterial activity of lactoferricin, lysozyme and EDTA against Salmonella enteritidis. Int. Dairy J. 1996, 6:303-313.
31. FitzGerald R.J., Meisel H. Lactokinins: Whey protein-derived ACE inhibitory peptides. Nahrung/Food 1999, 43:165-167.
32. Gattegno L., Migliore-Samour D., Saffar L., Jolles P. Enhancement of phagocytic activity of human monocytic-macrophagic cells by immunostimulating peptides from human casein. Immunol. Lett. 1988, 18:27-31.
33. Gauthier S.F., Pouliot Y. Functional and biological properties of peptides obtained by enzymatic hydrolysis of whey proteins. J. Dairy Sci. 2003, 86:78-87.
34. Gauthier S.F., Vachon C., Savoie L. Enzymatic conditions of an in vitro method to study protein digestion. J. Food Sci. 1986, 51:960-964.
35. Gerdes S.K., Harper J.W., Miller G. Applications Monograph: Cardiovascular Health Bioactive Components of Whey and Cardiovascular Health 2002, The American Dairy Products Institute, US Dairy Export Council, Chicago, IL.
36. Girardet J.M., Linden G., Loye S., Courthaudon J.L., Lorient D. Study of a mechanism of lipolysis inhibition by bovine milk proteose peptone component-3. J. Dairy Sci. 1993, 76:2156-2163.
37. 2: Studies using an in vitro digestion/Caco-2 cell model. J. Agric. Food Chem. 2002, 50:390-395.
38. Groenink J., Walgreen-Weterings E., van't Hof W., Veerman E.C., Amerongen A.V.N. Cationic amphipathic peptides, derived from bovine and human lactoferrins, with antimicrobial activity against oral pathogens. FEMS Microbiol. Lett. 1999, 179:217-222.
39. Grufferty M.B., Fox P.F. Milk alkaline proteinase. J. Dairy Res. 1988, 55:609-613.
40. Gurgel P.V., Carbonell R.G., Swaisgood H.E. Identification of peptide ligands generated by combinatorial chemistry that bind α-lactalbumin. Sep. Sci. Technol. 2001, 36:2411-2431.
41. Halken S., Hansen K.S., Jacobsen H.P., Estmann A., Faelling A.E., Hansen L.G., Kier S.R., Lassen K., Lintrup M., Mortensen M., Ibsen K.K., Osterballe O., Host A. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: A prospective randomized study. Pediatr. Allergy Immunol. 2000, 11:149-161.
42. Hammer J., Haheim H., Gutterberg T.J. Bovine lactoferrin is more efficient than bovine lactoferricin in inhibiting HSV-I/II replication in vitro. Lactoferrin: Structure, Functions, and Applications 2000, 239-243. Elsevier Science, Amsterdam, the Netherlands. K. Shimazaki (Ed.).
43. Hoek K.S., Milne J.M., Grieve P.A., Dionysius D.A., Smith R. Antibacterial activity of bovine lactoferrin-derived peptides. Antimicrob. Agents Chemother. 1997, 41:54-59.
44. Ibrahim E.H., Sherman G., Ward S., Fraser V.J., Kollef M.H. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000, 118:146-155.
45. Ijäs H., Collin M., Finckenberg P., Pihlanto-Leppälä A., Korhonen H., Korpela P., Vapaatalo H., Nurminem M.-L. Antihypertensive opioid-like milk peptide α-lactorphin: Lack of effect on behavioural tests in mice. Int. Dairy J. 2004, 14:201-205.
46. Ikeda M., Nozaki A., Sugiyama K., Tanaka T., Naganuma A., Tanaka K., Sekihara H., Shimotohno K., Saito M., Kato N. Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells. Virus Res. 2000, 66:51-63.
47. Iqbal G., López-Fandiño R., Jorba X., Vulfson E.N. Biologically active peptides and enzymatic approaches to their production. Enzyme Microb. Technol. 1996, 18:162-183.
48. Jack R.W., Bierbaum G., Sahl H.-G. Lantibiotics and Related Peptides 1998, Springer-Verlag, New York, NY.
49. Jaziri M., Migliore-Samour D., Casabianca-Pignède M.-R., Keddad K., Morgat J.-L., Jollès P. Specific binding sites on human phagocytic blood cells for Gly-Leu-Phe and Val-Glu-Pro-Ile-Pro-Tyr immunostimulating peptides from human milk proteins. Biochim. Biophys. Acta 1992, 1160:251-261.
50. Johnsen L.B., Sùrensen E.S., Petersen T.E., Berglund L. Characterization of a bovine mammary gland PP3 cDNA reveals homology with mouse and rat adhesion molecule GlyCAM-1. Biochim. Biophys. Acta 1995, 1260:116-118.
51. Kang J.H., Lee M.K., Kim K.L., Hahm K.-S. Structure-biological activity relationships of 11-residue highly basic peptide segment of bovine lactoferrin. Int. J. Pept. Protein Res. 1996, 48:357-363.
52. Kawasaki Y., Isoda H., Tanimoto M., Dosako S., Idota T., Ahiko K. Inhibition by lactoferrin and casein glycomacropeptide of binding of cholera toxin to its receptor. Biosci. Biotechnol. Biochem. 1992, 56:195-198.
53. Kawasaki Y., Kawakami H., Tanimoto M., Dosako S., Tomizawa A., Kotake M., Nakajima I. pH-Dependent molecular weight changes of κ-casein glycomacropeptide and its preparation by ultrafiltration. Milchwissenschaft 1993, 48:191-195.
54. Kayser H., Meisel H. Stimulation of human peripheral blood lymphocytes by bioactive peptides derived from bovine milk proteins. FEBS Lett. 1996, 383:18-20.
55. Kitchen B.J. Indigenous milk enzymes. Developments in Dairy Chemistry 1985, 3:239. Applied Science Publishers, London, UK.
56. Korhonen H. Antibacterial and antiviral activities of whey proteins, the importance of whey and whey components in food and nutrition. Proc. 3rd Int 2001, 303-321. Whey Conf., Munich, Germany.
57. Korhonen H., Pihlanto A. Bioactive peptides and proteins. Adv. Food Nutr. Res. 2003, 47:175-176.
58. Kruger M.C., Plimmer G.G., Schollum L.M., Haggarty N., Ram S., Palmano K. The effect of whey acidic protein fractions on bone loss in the ovariectomised rat. Br. J. Nutr. 2005, 94:244-252.
59. Lam S.M., Moughan P.J., Awati A., Morton H.R. The influence of whey protein and glycomacropeptide on satiety in adult humans. Physiol. Behav. 2009, 96:162-168.
60. Langley-Danysz P. Des hydrolysats protéiques pour développer des aliments santé. RIA Technol. Veille. 1998, 581:38-40.
61. Li E.W., Mine Y. Immunoenhancing effects of bovine glycomacropeptide and its derivatives on the proliferative response and phagocytic activities of human macrophage-like cells U937. J. Agric. Food Chem. 2004, 52:2704-2708.
62. Lupetti A., Paulusma-Annema A., Welling M.M., Senesi S., van Dissel J.T., Nibbering P.H. Candidacidal activities of human lactoferrin peptides derived from the N terminus. Antimicrob. Agents Chemother. 2000, 44:3257-3263.
63. Madureira A.R., Pereira C.I., Gomes A.M.P., Pintado M.E., Malcata F.X. Bovine whey proteins-Overview on the main biological properties. Food Res. Int. 2007, 40:1197-1211.
64. Maeno M., Yamamoto N., Takano T. Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790. J. Dairy Sci. 1996, 79:1316-1321.
65. Maes W., van Camp J., Vermeirssen V., Hemeryck M., Ketelslegers J.M., Chrezenmeir J., van Oosteveldt P., Huyghebaert A. Influence of the lactokinin Ala-Leu-Pro- Met-His-Ile-Arg (ALPMHIR) on the release of endothelin-1 by endothelial cells. Regul. Pept. 2004, 118:105-109.
66. Marshall S.C. Casein macropeptide from whey-A new product opportunity. Food Res. Quart. 1991, 51:86-89.
67. Martin-Esteban M., Garcia-Ara M.C., Banque-Molas M., Boyano-Martinez M.T., Martin-Munoz F., Diaz-Pena J.M. Evaluation of an extensively hydrolyzed casein-whey protein formula in immediate cow's milk protein hypersensitivity. J. Pediatr. Gastroenterol. Nutr. 1998, 26:398-401.
68. 1-casein. Agric. Biol. Chem. 1987, 54:2557-2561.
69. Mattsby-Balzer I., Roseanu A., Motas C., Elverfors J., Engberg I., Hanson L.A. Lactoferrin or a fragment thereof inhibits the endotoxin-induced interleukin-6 response in human monocytic cells. Pediatr. Res. 1996, 40:257-262.
70. McCann K.B., Lee A., Wan J., Roginski H., Coventry M.J. The effect of bovine lactoferrin and lactoferricin B on the ability of feline calicivirus (a norovirus surrogate) and poliovirus to infect cell cultures. J. Appl. Microbiol. 2003, 95:1026-1033.
71. Meisel H. Overview on milk protein-derived peptides. Int. Dairy J. 1998, 8:363-373.
72. Meisel H., FitzGerald R.J. Biofunctional peptides from milk proteins, mineral binding and cytomodulatory effects. Curr. Pharm. Des. 2003, 9:1289-1295.
73. Meisel H., Schlimme E. Bioactive peptides derived from milk proteins: Ingredients for functional foods?. Kieler Milchwirts. Forsch. 1996, 48:343-357.
74. Mercier A., Gauthier S.F., Fliss I. Immunomodulating effects of whey proteins and their enzymatic digests. Int. Dairy J. 2004, 14:175-183.
75. Mills E.N.C., Alcocer M.J.C., Morgan M.R.A. Biochemical interactions of food-derived peptides. Trends Food Sci. Technol. 1992, 3:64-68.
76. Minekus M., Marteau P., Havenaar R., Huis in't Veld J.H.J. A multi compartmental dynamic computer-controlled model simulating the stomach and small intestine. ATLA 1995, 23:197-209.
77. Molly K., van de Woestyne M., Verstraete W. Development of a 5-step multi-chamber reactor as a simulation of the human intestinal microbial ecosystem. Appl. Microbiol. Biotechnol. 1993, 39:254-258.
78. Mullally M.M., Meisel H., FitzGerald R.J. Synthetic peptides corresponding to α-LA and β-LG sequences with angiotensin-I-converting enzyme inhibitory activity. Biol. Chem. Hoppe Seyler 1996, 377:259-260.
79. Mullally M.M., Meisel H., FitzGerald R.J. Angiotensin-I-converting enzyme inhibitory activities of gastric and pancreatic proteinase digests of whey proteins. Int. Dairy J. 1997, 7:299-303.
80. Murakami M., Tonouchi H., Takahashi R., Kitazawa H., Kawai Y., Negishi H., Saito T. Structural analysis of a new anti-hypertensive peptide (β-lactosin B) isolated from a commercial whey product. J. Dairy Sci. 2004, 87:1967-1974.
81. Nagaoka S., Futumura Y., Miwa K., Awano T., Yamauchi K., Kanamaru Y., Tadashi K., Kuwata T. Identification of novel hypocholesterolemic compound derived from bovine milk beta-lactoglobulin. Biochem. Biophys. Res. Commun. 2001, 281:11-17.
82. Nakamura Y., Yamamoto N., Sakai K., Takano T. Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme. J. Dairy Sci. 1995, 78:1253-1257.
83. Neeser J.-R., Chambaz A., del Vedovo S., Prigent M.-J., Guggenheim B. Specific and nonspecific inhibition of adhesion of oral actinomyces and streptococci to erythrocytes and polystyrene by caseinoglycopeptide derivatives. Infect. Immun. 1988, 56:3201-3208.
84. Nurminen M.-L., Sipola M., Kaarto H., Pihlanto-Leppälä A., Piilola K., Korpela R., Tossavainen O., Korhonen H.J.T., Vapaatalo H. α-Lactorphin lowers blood pressure measured by radiotelemetry in normotensive and in spontaneously hypertensive rats. Life Sci. 2000, 66:1535-1543.
85. Ohinata K., Inui A., Asakawa A., Wada K., Wada E., Yoshikawa M. Albutensin A and complement C3a decrease food intake in mice. Peptide 2002, 27:127-133.
86. Ondetti M.A., Cushman D.W. Enzymes of the renin-angiotensin system and their inhibitors. Annu. Rev. Biochem. 1982, 51:283-308.
87. Oomen A.G., Hack A., Minekus M., Zeijdner E., Cornelis C., Schoeters G., Verstraete W., van de Wiele T., Wragg J., Rompelberg C.J.M., Sips A., van Wijnen J.H. Comparison of five in vitro digestion models to study the bioaccessibility of soil contaminants. Environ. Sci. Technol. 2002, 36:3326-3334.
88. Ortiz-Chao P., Gomez-Ruiz J.A., Rastall R.A., Mills D., Cramer R., Pihlanto A., Korhonen H., Jauregi P. Production of novel ACE inhibitory peptides from β-lactoglobulin using Protease N Amano. Int. Dairy J. 2009, 19:69-76.
89. Pecquet S., Bovetto L., Maynard F., Fritsché R. Peptides obtained by tryptic hydrolysis of bovine β-lactoglobulin induce specific oral tolerance in mice. J. Allergy Clin. Immunol. 2000, 105:514-521.
90. Pellegrini A., Dettling C., Thomas U., Hunziker P. Isolation and characterisation of four bactericidal domains in the bovine α-lactoglobulin. Biochim. Biophys. Acta 2000, 1526:131-140.
91. Pellegrini A., Thomas U., Bramaz N., Hunziker P., von Fellenberg R. Isolation and identification of three bactericidal domains in the bovine α-lactalbumin molecule. Biochim. Biophys. Acta 1999, 1426:439-448.
92. Perea A., Ugalde U. Continuous hydrolysis of whey proteins in a membrane recycle reactor. Enzyme Microb. Technol. 1996, 18:29-34.
93. Pietrantoni A., Ammendolia M.G., Tinari A., Siciliano R., Valenti P., Superti F. Bovine lactoferrin peptidic fragments involved in inhibition of echovirus 6 in vitro infection. Antivir. Res. 2006, 69:98-106.
94. Pihlanto-Leppälä A., Koskinen P., Piilola K., Tupasela T., Korhonen H. Angiotensin I-converting enzyme inhibitory properties of whey protein digests: Concentration and characterization of active peptides. J. Dairy Res. 2000, 67:53-64.
95. Pihlanto-Leppälä A., Paakkari I., Rinta-Koski M., Antila P. Bioactive peptide derived from in vitro proteolysis of bovine β-lactoglobulin and its effect on smooth muscle. J. Dairy Res. 1997, 64:149-155.
96. Pihlanto-Leppälä A., Rokka T., Korhonen H. Angiotensin I-converting enzyme inhibitory peptides from bovine milk proteins. Int. Dairy J. 1998, 8:325-331.
97. Pins J.J., Keenan J.M. Effects of whey peptides on cardiovascular disease risk factors. J. Clin. Hypertens. 2006, 8:775-782.
98. Potter S. Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J. Nutr. 1995, 125:606-611.
99. Prioult G., Pecquet S., Fliss I. Stimulation of interleukin-10 production by acidic beta-lactoglobulin-derived peptides hydrolyzed with Lactobacillus paracasei NCC2461 peptidases. Clin. Diagn. Lab. Immunol. 2004, 11:266-271.
100. Recio I., Visser S. Two ion-exchange chromatographic methods for the isolation of antibacterial peptides from lactoferrin: In situ enzymatic hydrolysis on an ion-exchange membrane. J Chromatogr. 1999, 831:191-201.
101. Reid I. R., J. Cornish, N. W. Haggarty, and K. P. Palmano. 2004. Bone health compositions derived from milk. US patent US2004052860. New Zealand Dairy Board, assignee.
102. Roufik S., Gauthier S.F., Sylvie L.T. Physicochemical characterization and in vitro digestibility of β-lactoglobulin/β-Lg f142-148 complexes. Int. Dairy J. 2007, 7:471-480.
103. Roufik S., Gauthier S.F., Turgeon S.L. In vitro digestibility of bioactive peptides derived from bovine β-lactoglobulin. Int. Dairy J. 2006, 16:294-302.
104. Saint-Sauveur D., Gauthier S.F., Boutin Y., Montoni A., Fliss I. Effect of feeding whey peptide fractions on the immune response in healthy and Escherichia coli infected mice. Int. Dairy J. 2009, 19:537-544.
105. Saito T., Nakamura T., Kitazawa H., Kawai Y., Itoh T. Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese. J. Dairy Sci. 2000, 83:1434-1440.
106. Samuelsen Ø., Haukland H.H., Ulvatne H., Vorland L.H. Anti-complement effects of lactoferrin-derived peptides. FEMS Immunol. Med. Microbiol. 2004, 41:141-148.
107. Schmidt R.H., Packardm V.S., Morris H.A. Effects of processing on whey protein functionality. J. Dairy Sci. 1984, 67:2723-2733.
108. Schupbach P., Neeser J.R., Golliard M., Rouvet M., Guggenheim B. Incorporation of caseinoglycomacropeptide and caseinophosphopeptide into the salivary pellicle inhibits adherence of mutant streptococci. J. Dent. Res. 1996, 75:1779-1788.
109. Scollard P.G., Beresford T.P., Murphy P.M., Kelly A.L. Barostability of milk plasmin activity. Lait 2000, 80:609-619.
110. Shah N.P. Effects of milk-derived bioactives: An overview. Br. J. Nutr. 2000, 84(Suppl. 1):S3-S10.
111. Shimazaki K., Tazume T., Uji K., Tanaka M., Kumura H., Mikawa K., Shimo-Oka T. Properties of a heparin-binding peptide derived from bovine lactoferrin. J. Dairy Sci. 1998, 81:2841-2849.
112. Shin K., Yamauchi K., Teraguchi S., Hayasawa H., Tomita M., Otsuka Y., Yamazaki S. Antibacterial activity of bovine lactoferrin and its peptides against enterohaemorrhagic Escherichia coli O157 7. Lett. Appl. Microbiol. 1998, 26:407-411.
113. Siciliano R., Rega B., Marchetti M., Seganti L., Antonini G., Valenti P. Bovine lactoferrin peptidic fragments involved in inhibition of herpes simplex virus type 1 infection. Biochem. Biophys. Res. Commun. 1999, 264:19-23.
114. Silva S.V., Malcata F.X. Caseins as source of bioactive peptides. Int. Dairy J. 2004, 15:1-15.
115. Sipola M., Finckenberg P., Korpela R., Vapaatalo H., Nurminen M.-L. Effect of long-term intake of milk products on blood pressure in hypertensive rats. J. Dairy Res. 2002, 69:103-111.
116. Smacchi E., Gobbetti M. Bioactive peptides in dairy products, synthesis and interaction with proteolytic enzymes. Food Microbiol. 2000, 17:129-141.
117. Smithers G.W., Ballard J.B., Copeland A.D., Kirthi J.A., Dionysius D.A., Francis G.L., Goddard C., Grieve P.A., Mcintosh G.H., Mitchell I.R., Pearce R.J., Regester G.O. Symposium: Advances in dairy foods processing and engineering new opportunities from the isolation and utilization of whey proteins. J. Dairy Sci. 1996, 79:1454-1459.
118. Sorensen E.S., Petersen T. Purification and characterization of three proteins from the proteose peptone fraction of bovine milk. J. Dairy Res. 1993, 60:189-197.
119. Sorensen E.S., Rasmussen L.K., Moller L., Petersen T.E. The localization and multimeric nature of component PP3 in bovine milk: Purification and characterization of PP3 from caprine and ovine milks. J. Dairy Sci. 1997, 80:3176-3181.
120. Takahashi M., Moriguchi S.M., Suganuma T., Shiota H., Takenaka A., Tani Y., Ryuzo F.S., Yoshikawa M. Albutensin A an ileum-contracting peptide derived from serum albumin acts through both receptors for complements C3a and C5a. Lett. Pept. Sci. 1998, 5:29-35.
121. Tani F., Shiota A., Chiba H., Yoshikawa M. Serophin an opioid peptide derived from bovine serum albumin. β-Casomorphins and Related Peptides: Recent Developments 1993, 49-53. VCH-Verlag, Weinheim, Germany. V. Brantl (Ed.).
122. Tomé D., Ledoux N. Nutritional and physiological role of milk protein components. Dairy Foods in Health Bulletin of the International Dairy Federation 1998, 336. International Dairy Federation, Brussels, Belgium, 11-16.
123. Tomita M., Bellamy W., Takase M., Yamauchi K., Wakabayashi H., Kawase K. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J. Dairy Sci. 1992, 74:4137-4142.
124. Tyler-McMahon B.M., Bolles M., Richelson E. Neurotensin: Peptide for the next millennium. Regul. Pept. 2000, 93:125-126.
125. van der Kraan M.I.A., Groenink J., Nazmi K., Veerman E.C.I., Bolscher J.G.J., Amerongen A.V.N. Lactoferrampin: A novel antimicrobial peptide in the N1-domain of bovine lactoferrin. Peptides 2004, 25:177-183.
126. van der Kraan M.I.A., Nazmi K., Teeken A., Groenink J., van't Hoff W., Veerman E.C.I. Lactoferrampin an antimicrobial peptide of bovine lactoferrin exhibits its candidacidal activity by a cluster of positively charged residues at the C-terminus in combination with a helix facilitating N-terminal part. J. Biol. Chem. 2005, 386:137-142.
127. Vermeirssen V., Deplacke B., Tappenden K.A., van Camp J., Gaskins H.R., Verstraete W. Intestinal transport of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg through a Caco-2 Bbe monolayer. J. Pept. Sci. 2002, 8:95-100.
128. Viejo-Díaz M., Andrés M.T., Fierro J.F. Different anti-Candida activities of two lactoferrin-derived peptides Lfpep and kaliocin-1. Antimicrob. Agents Chemother. 2005, 49:2583-2588.
129. Vogel H.J., Shibli D.J., Jing W., Lohmeiher-Vogel E.M., Epand R.F., Epand R.M. Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides. Biochem. Cell Biol. 2002, 80:49-63.
130. Vorland L.H., Ulvatne H., Rekdal O., Svendsen J.S. Initial binding sites of antimicrobial peptides in Staphylococcus aureus and Escherichia coli. Scand. J. Infect. Dis. 1999, 31:467-473.
131. Wakabayashi H., Abe S., Okutomi T., Tansho S., Kawase K., Yamaguchi H. Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents. Microbiol. Immunol. 1996, 40:821-825.
132. Wakabayashi H., Matsumoto H., Hashimoto K., Teraguchi S., Takase M., Hayasawa H. N-Acylated and d-enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activity. Antimicrob. Agents Chemother. 1999, 43:1267-1269.
133. Wakabayashi H., Takase M., Tomita M. Lactoferricin derived from milk protein lactoferrin. Curr. Pharm. Des. 2003, 9:1277-1287.
134. Walsh D.J., Bernard H., Murray B.A., MacDonald J., Pentzien A.-K., Wright G.A., Wal J.-M., Struthers A.D., Meisel H., FitzGerald R.J. In vitro generation and stability of the lactokinin β-lactoglobulin fragment (142-148). J. Dairy Sci. 2004, 87:3845-3857.
135. Wong K.F., Middleton N., Montgomery M., Dey M., Carr R.I. Immunostimulation of murine spleen cells by materials associated with bovine milk protein fractions. J. Dairy Sci. 1998, 81:1825-1832.
136. Yamamoto N., Maeno M., Takano T. Purification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticus CPN4. J. Dairy Sci. 1999, 82:1388-1393.
137. Yamauchi K. Biologically functional proteins of milk and peptides derived from milk proteins. Bull. Int. Dairy Fed. 1992, 272:51-58.
138. Yamauchi K., Tomita M., Giehl T.J., Ellison R.T. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect. Immun. 1993, 61:719-728.
139. Yamauchi R., Ohinata K., Yoshikawa M. β-Lactotensin and neurotensin rapidly reduce serum cholesterol via NT2 receptor. Peptides 2003, 24:1955-1961.
140. Yamauchi R., Usui H., Yunden J., Takenaka Y., Tani F., Yoshikawa M. Characterization of β-lactotensin a bioactive peptide derived from bovine β-lactoglobulin as a neurotensin agonist. Biosci. Biotechnol. Biochem. 2003, 67:940-943.
141. Yvon M., Beucher S., Guilloteau P., le Huerou-Luron I., Corring T. Effects of caseinomacropeptide (CMP) on digestion regulation. Reprod. Nutr. Dev. 1994, 34:527-537.
142. Yvon M., Beucher S., Scanff P., Thirouin S., Pelissier J.P. In vitro simulation of gastric digestion of milk proteins: Comparison between in vitro and in vivo data. J. Agric. Food Chem. 1992, 40:239-244.
143. Zhang X., Beynen A.C. Influence of dietary fish proteins on plasma and liver cholesterol concentrations in rats. Br. J. Nutr. 1993, 69:767-777.